DAVID GOEN: Open Payments
NPI 1700238433 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 27 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $342 · 2025 $633
Food & beverage: $557Education: $76
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $197 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $157 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $98 |
| Almatica Pharma LLC | 3 | $79 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| ABBVIE INC. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $20 |
Products named: TRINTELLIX, AUSTEDO XR, CAPLYTA, LOREEV XR, REXULTI, VRAYLAR, Auvelity.
Industry payments across AZ — which companies pay providers there.
